ConductScience.org, home

Paper314301

Low natural-killer-cell activity in familial melanoma patients and their relatives.

Hersey P and 3 others. Br J Cancer, 1979. Cited by 133 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Low natural-killer-cell activity in familial melanoma patients and their relatives. Papers, record 314301. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/314301

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Low natural-killer-cell activity in familial melanoma patients and their relatives.
PubMed
Journal
Br J Cancer
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
133
iCite
Relative citation ratio, by iCite
2.89
iCite
Revised in PubMed
2019-05-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hersey PP
2Edwards AA
3Honeyman MM
4McCarthy WHW H

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
MelanomaMajor topic
Adult
Aged
B-Lymphocytes
Child
Cytotoxicity, Immunologic
Female
Humans
Immunity, Innate
Male
Middle Aged
Mitosis
Phytohemagglutinins
Receptors, Antigen, B-Cell
Rosette Formation

Source PubMed

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
280,299Natural killer cells in the mouse: an alternative immune surveillance mechanism?Contemp Top Immunobiol1978https://conductscience.org/library/papers/80299PubMed
3111,695Relationship of natural killer-cell activity to rhesus antigens in man.Br J Cancer1979https://conductscience.org/library/papers/111695PubMed
4322,460Current concepts of the biology of human cutaneous malignant melanoma.Adv Cancer Res1977https://conductscience.org/library/papers/322460PubMed
5705,260Target--effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse.Scand J Immunol1978https://conductscience.org/library/papers/705260PubMed
6646,923Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients.Br J Cancer1978https://conductscience.org/library/papers/646923PubMed
74,739,655HL-A antigens in solid tumors.Cancer Res1973https://conductscience.org/library/papers/4739655PubMed
84,131,425Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays.J Natl Cancer Inst1974https://conductscience.org/library/papers/4131425PubMed
94,600,315An improved rosetting assay for detection of human T lymphocytes.J Immunol Methods1974https://conductscience.org/library/papers/4600315PubMed
10240,887Studies of surface immunoglobulins on human B lymphocytes. I. Dissociation of cell-bound immunoglobulins with acid pH or at 37 degrees C.J Immunol1975https://conductscience.org/library/papers/240887PubMed
111,150,347Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line.Int J Cancer1975https://conductscience.org/library/papers/1150347PubMed
125,096,934Clinical characteristics of the genetic variety of cutaneous melanoma in man.Cancer1971https://conductscience.org/library/papers/5096934PubMed

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 133 citations.

PMIDTitleJournalYearIn PapersSource
40,805,135Supercharged Natural Killer (sNK) Cells Inhibit Melanoma Tumor Progression and Restore Endogenous NK Cell Function in Humanized BLT Mice.Cancers (Basel)2025https://conductscience.org/library/papers/40805135PubMed
39,851,518Natural Killer Cell-Secreted IFN-γ and TNF-α Mediated Differentiation in Lung Stem-like Tumors, Leading to the Susceptibility of the Tumors to Chemotherapeutic Drugs.Cells2025https://conductscience.org/library/papers/39851518PubMed
38,334,605Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy.Cells2024https://conductscience.org/library/papers/38334605PubMed
38,057,843The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies.Cancer Cell Int2023https://conductscience.org/library/papers/38057843PubMed
37,275,901Immunometabolic reprogramming, another cancer hallmark.Front Immunol2023https://conductscience.org/library/papers/37275901PubMed
36,417,048The use of natural killer cell activity and PPD test in the prediction of results in intravesical BCG treatment of patients with nonmuscle-invasive bladder cancer.Int Urol Nephrol2023https://conductscience.org/library/papers/36417048PubMed
36,032,129Innate lymphoid cells in early tumor development.Front Immunol2022https://conductscience.org/library/papers/36032129PubMed
35,967,421Natural killer cells: the next wave in cancer immunotherapy.Front Immunol2022https://conductscience.org/library/papers/35967421PubMed
35,507,102Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity.Cancer Immunol Immunother2022https://conductscience.org/library/papers/35507102PubMed
35,326,467Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions.Cells2022https://conductscience.org/library/papers/35326467PubMed
34,878,657A functional variant in the immune signalling receptor NKG2D alters skin cancer risk.Br J Dermatol2022https://conductscience.org/library/papers/34878657PubMed
34,445,750Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.Int J Mol Sci2021https://conductscience.org/library/papers/34445750PubMed
34,201,655MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.Int J Mol Sci2021https://conductscience.org/library/papers/34201655PubMed
33,802,954Targeting NK Cells to Enhance Melanoma Response to Immunotherapies.Cancers (Basel)2021https://conductscience.org/library/papers/33802954PubMed
31,167,464Mast Cells and Natural Killer Cells-A Potentially Critical Interaction.Viruses2019https://conductscience.org/library/papers/31167464PubMed
30,761,123CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α.Front Immunol2019https://conductscience.org/library/papers/30761123PubMed
30,298,063Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.Front Immunol2018https://conductscience.org/library/papers/30298063PubMed
30,282,672PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients.Cancer Immunol Res2018https://conductscience.org/library/papers/30282672PubMed
28,424,683Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients.Front Immunol2017https://conductscience.org/library/papers/28424683PubMed
28,360,428Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy.Exp Mol Med2017https://conductscience.org/library/papers/28360428PubMed

See all 47 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABO28PubTator's text mininghttps://conductscience.org/library/genes/28NCBI Gene
HLA-A3,105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/314301

GET https://conductscience.org/api/papers/v1/314301/cited_by?page=2